Komori
General Meetings of Shareholders4569KYORIN Pharmaceutical Co.,Ltd.Pharmaceuticals

Notice of Convocation of the 68th Annual General Meeting of Shareholders and General Meeting Materials

For the 68th Annual General Meeting of Shareholders, proposals have been submitted for the appointment of 6 directors and 4 Audit & Supervisory Board members. The director candidates include 3 new candidates, 2 of whom are outside directors, while the Audit & Supervisory Board member candidates include 2 new candidates, 1 of whom is an outside member.

Worth reading
55In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual, 68th
2026
Jun 19
Date and time22 days from this disclosure to the meeting
Matters for resolution2 items
  1. Election of 6 directors

  2. Appointment of 4 Audit & Supervisory Board members

Shareholder Proposal

No

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
6Nominees
2New
3Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual, 68th
Date and time10:00 a.m. on Friday, 19 June 2026
Matters for resolutionProposal No. 1: Election of 6 directors, Proposal No. 2: Appointment of 4 Audit & Supervisory Board members
Shareholder ProposalNo
Director nominee6, including 2 new candidates and 3 outside directors
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Following the expiration of the terms of office of the directors and Audit & Supervisory Board members, the company is seeking the appointment of successors. Each candidate is expected to draw on their experience and expertise in areas including management, healthcare, legal affairs, research and development, and finance to make important management decisions, oversee the execution of business, or conduct audits.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 68th Annual General Meeting of Shareholders and General Meeting Materials | KYORIN Pharmaceutical Co.,Ltd. (4569) timely disclosure | Komori